Alveolar Soft Part Sarcoma: Clinical Trials

1 trial for Alveolar Soft Part Sarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1
Phase 31Completed 1

Follow Alveolar Soft Part Sarcoma: new trials by email Literature Review of Alveolar Soft Part Sarcoma trials Research Report on Alveolar Soft Part Sarcoma

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery
Doxorubicin, Doxorubicin Hydrochloride, Ifosfamide - Alveolar Soft Part Sarcoma, Angiomatoid Fibrous Histiocytoma
Phase 2 / Phase 3CompletedNational Cancer Institute (NCI)1402014-08-122026-06-17

Narrower conditions

Chondrosarcoma, Extraskeletal Myxoid (1)  ·  Chondrosarcoma, Mesenchymal (1)  ·  Dermatofibrosarcoma (1)  ·  Fibrosarcoma (1)  ·  Granuloma, Plasma Cell (1)  ·  Histiocytoma, Angiomatoid Fibrous (1)  ·  Histiocytoma, Malignant Fibrous (1)  ·  Leiomyosarcoma (1)  ·  Liposarcoma (1)  ·  Nerve Sheath Neoplasms (1)  ·  Neurofibrosarcoma (1)  ·  Perivascular Epithelioid Cell Neoplasms (1)  ·  Sarcoma (1)  ·  Sarcoma, Alveolar Soft Part (1)  ·  Sarcoma, Clear Cell (1)

Broader conditions

Chondrosarcoma (1)  ·  Granuloma (1)  ·  Histiocytoma (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Adipose Tissue (1)  ·  Neoplasms, Connective Tissue (1)  ·  Neoplasms, Connective and Soft Tissue (1)  ·  Neoplasms, Fibrous Tissue (1)  ·  Neoplasms, Muscle Tissue (1)  ·  Neoplasms, Nerve Tissue (1)  ·  Nervous System Diseases (1)  ·  Nervous System Neoplasms (1)  ·  Neurofibroma (1)  ·  Neuromuscular Diseases (1)

Interventions

Doxorubicin (1)  ·  Ifosfamide (1)  ·  Radiation (1)  ·  Radiotherapy (1)  ·  pazopanib (1)

Sponsors

National Cancer Institute (NCI) (1)

Countries

Canada (1)  ·  Puerto Rico (1)  ·  United States (1)

Top investigators

Aaron R Weiss (1)

Results publications

PMID 32702309, PMID 32827353, PMID 34515544, PMID 37523624

NIH funding

U10CA098543 (1), U10CA180830 (1), U10CA180886 (1)